How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Neurology Digital Therapeutics Market
- By Therapeutic Application: Migraine Management, Epilepsy Control, Multiple Sclerosis Rehabilitation, Parkinson's Disease Symptom Management, Stroke Recovery
- By Delivery Platform: Mobile Applications, Wearable Devices, Virtual Reality Systems, Web-based Platforms, Telehealth Integration
- By End User: Patients, Healthcare Providers, Caregivers, Clinical Researchers
- By Technology Type: Cognitive Behavioral Therapy (CBT) Modules, Neurofeedback Systems, Biofeedback Devices, Gamified Therapy Solutions, Artificial Intelligence-driven Personalization
- By Mode of Therapy: Self-guided Therapy, Clinician-guided Therapy, Hybrid Therapy Models
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Migraine Management leads By Therapeutic Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the Neurology Digital Therapeutics Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Therapeutic Application 5
Delivery Platform 5
End User 4
Technology Type 5
Mode of Therapy 3
Companies profiled
Pear Therapeutics
Akili Interactive Labs
NeuroSigma
Happify Health
Mayo Clinic Ventures (digital therapeutics division)
Kaia Health
CureApp
Click Therapeutics
Omada Health
Big Health
MindMaze
Biofourmis
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Pear Therapeutics
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Akili Interactive Labs
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →NeuroSigma
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Happify Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Mayo Clinic Ventures (digital therapeutics division)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Kaia Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →CureApp
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Click Therapeutics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Omada Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Big Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →MindMaze
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Biofourmis
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Sano Intelligence
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Limbix
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →MyndYou
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,551M by 2033 · 8.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Migraine Management37.1
- Epilepsy Control9.1
- Multiple Sclerosis Rehabilitation20.4
- Parkinson's Disease Symptom Management13.2
- Stroke Recovery20.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$424.4M → $837.1M · 8.9%
Europe$295.8M → $594.5M · 9.1%
Asia Pacific$270.1M → $584.1M · 10.1%
Latin America$167.2M → $309.5M · 8.0%
Middle East and Africa$128.6M → $266.5M · 9.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.892026
8.912027
8.922028
8.922029
8.942030
8.942031
8.972032
8.982033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Pear Therapeutics10.8
- Akili Interactive Labs26.4
- NeuroSigma7.9
- Happify Health10.9
- Mayo Clinic Ventures (digital therapeutics division)8.7
- Kaia Health7.4
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Therapeutic Application14.7%
Delivery Platform25.3%
End User14.3%
Technology Type31.1%
Mode of Therapy14.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.3
- Europe22.9
- Asia Pacific22.5
- Latin America11.9
- Middle East and Africa10.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Pear Therapeutics | 93 | 77 | 82 | 74 | 85 | 93 | 84 |
| Akili Interactive Labs | 75 | 76 | 81 | 68 | 75 | 83 | 76 |
| NeuroSigma | 75 | 82 | 65 | 76 | 82 | 84 | 77 |
| Happify Health | 66 | 73 | 71 | 76 | 63 | 65 | 69 |
| Mayo Clinic Ventures (digital therapeutics division) | 55 | 52 | 54 | 74 | 73 | 72 | 63 |
| Kaia Health | 60 | 48 | 56 | 47 | 55 | 63 | 55 |
| CureApp | 55 | 56 | 60 | 41 | 44 | 43 | 50 |
| Click Therapeutics | 56 | 40 | 50 | 56 | 50 | 55 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Pear Therapeutics
- Akili Interactive Labs
- NeuroSigma
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Pear Therapeutics | ✓ | ✓ | ◐ | ◐ | ◐ | ✓ |
| Akili Interactive Labs | − | ◐ | ✓ | ◐ | ✓ | ◐ |
| NeuroSigma | ◐ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Happify Health | ◐ | − | ◐ | ◐ | − | ✓ |
| Mayo Clinic Ventures (digital therapeutics division) | − | − | − | ✓ | ✓ | ✓ |
| Kaia Health | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| CureApp | − | ◐ | − | − | − | − |
| Click Therapeutics | − | − | ◐ | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Pear Therapeutics84
2NeuroSigma77
3Akili Interactive Labs76
4Happify Health69
5Mayo Clinic Ventures (digital therapeutics division)63
6Kaia Health55
7Click Therapeutics51
8CureApp50
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Pear Therapeutics
Challenger3
Strong scale, closing on the leaders.
Akili Interactive LabsNeuroSigmaHappify Health
Contender1
Focused players with pockets of strength.
Mayo Clinic Ventures (digital therapeutics division)
Niche3
Specialists in a single segment or region.
Kaia HealthCureAppClick Therapeutics
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Therapeutic Application in North America, then scale across Neurology Digital Therapeutics Market — a $223M beachhead inside a $3.75B market.
Beachhead (SOM)$223Mobtainable near-term
Serviceable (SAM)$1.33Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Migraine Management
Best fit — highest urgency & budget in Therapeutic Application.
Economic buyer81 fit
Epilepsy Control
Strong fit — clear ROI and a fast path to value.
End user64 fit
Multiple Sclerosis Rehabilitation
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Therapeutic Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Delivery Platform & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel28%
Digital / self-serve20%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Therapeutic Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Neurology Digital Therapeutics Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified22%
Evaluation12%
Closed-won5%
$21.3KCAC
$120KLTV
5.6:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Neurology Digital Therapeutics Market is a resilient opportunity — $3.86B by 2033, compounding at 3.4%.
TAM · 2025$2.97Btoday
TAM · 2033$3.86Bforecast
CAGR3.4%2027–2033
Cumulative$30.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.86BTotal addressable market
SAM$1.32BServiceable available market
SOM$223MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.4% CAGR
Demand compounds through 2033, outpacing GDP across Therapeutic Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Therapeutic Application moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.86BLarge & growingTAM by 2033 at 3.4% CAGR
$1.32BServiceable nowreachable with today’s model
$223MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.01BBear2.2% CAGR
$3.86BBase3.4% CAGR
$4.94BBull4.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Delivery Platform optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Neurology Digital Therapeutics Market — a $9.24B market by 2033. Plan: grow share from 7.9% to 12.7%.
Market size · 2033$9.24Btotal addressable
Market CAGR6.9%2027–2033
Target share12.7%from 7.9% today
Revenue ambition$1.17Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.9% | 12.7% | Behind |
| Revenue | $764M | $1.17B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 32.6% | 44.0% | On track |
| Customer retention | 91.8% | 96.7% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Therapeutic Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Delivery Platform capability
A defensible second engine — invest in Delivery Platform to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Therapeutic Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Delivery Platform
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $149M capacity & capability investment
- Greenlight bolt-on M&A in Delivery Platform
- Authorise North America expansion plan
- Fund R&D program for Therapeutic Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Neurology Digital Therapeutics Market conversation — a $8.12B market you can size, segment and defend in minutes.
Market size · 2033$8.12Btotal opportunity
Growth11.1%CAGR to 2033
Addressable buyers1,563+accounts in scope
Typical ROI4.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Therapeutic Application
Goal Grow share in Therapeutic Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.7×return on cost, year one
< 2 mopayback period
$97K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Pear TherapeuticsAkili Interactive LabsNeuroSigmaHappify HealthMayo Clinic Ventures (digital therapeutics division)Kaia HealthCureAppClick Therapeutics+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Neurology Digital Therapeutics Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Neurology Digital Therapeutics Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Neurology Diagnostics Devices Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportNeurology Clinical Trial Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportNeurology and Neurosurgery EMR Software Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportNeurologic Disorder Treatment Drug Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportNeurological Monitoring Device Market
Neurological Monitoring Device Market is valued at USD 5.2 Billion in 2025 and is expected to r…
$5.2B market · 2025 base year
View reportNeurological Game Technology Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportNeurological Drugs Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportNeurological Devices Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportNeurological Biomarkers Market
Market size, share, segmentation and regional forecast.
$555M market · 2025 base year
View reportNeurological Biomarkers for Alzheimer`s and Parkinson`s Diseases Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportNeuro-intervention Micro-guide Wire Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportNeuro Intervention Intermediate Catheter Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.